The COVID-19 vaccine from AstraZeneca It is more effective against the virus in Mexicans, according to the National Institute of Public Health (INSP).
Studies show that the efficacy of this vaccine is 63.09 percent against the symptomatic infection of the SARS-CoV-2 virus, but in Mexico showed a 90 percent effectiveness in severe COVID and death in people with a complete scheme, said Celia Alpuche Aranda, a researcher at the INSP.
With a single dose, this vaccine offers a protection of 54 percent, which rises above 84, 85 and 88 percent.
“Protection against serious forms and hospitalizations and death is above 90 percent,” explained the director of the Research Center for Infectious Diseases of the INSP during the transmission of a virtual forum of Millennium.
Regarding the vaccine combination, the specialist stressed that there is only safety data on antigens from AstraZeneca with Sputnik V Y AstraZeneca con Pfizer, but the Government of Mexico maintains the vaccination schedule with the same doses because it has proven to be effective and safe.
The Astra Zeneca vaccine It was approved by the World Health Organization (WHO) and by the Federal Commission for the Protection against Sanitary Risks (Cofepris) for your emergency use. This, after exhaustively evaluating the data on its quality, safety and efficacy.
According to the WHO, the antigen has a 63.09 percent efficiency against symptomatic infection by the SARS-CoV-2 virus.
The most frequent events associated with this vaccine found were pain at the injection site, fatigue, headache, myalgia (muscle pain), arthralgia (joint pain) and fever, which were of mild to moderate intensity and resolved within 48 hours of vaccination.
– .
